T1	PROC 46 79	Estudio de la seguridad, eficacia
T2	PROC 97 108	monoterapia
#1	AnnotatorNotes T2	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T3	DISO 124 152	artrosis de cadera o rodilla
T4	ANAT 145 152	rodilla
#2	AnnotatorNotes T4	C0022742; Knee; Body Part, Organ, or Organ Component | C1283838; Entire knee region; Body Location or Region | C1963703; Knee region structure; Body Location or Region
T5	PROC 184 267	Estudio aleatorizado de 16 semanas, multifase, doble ciego y controlado con placebo
T6	CHEM 323 333	fulranumab
#3	AnnotatorNotes T6	C2981231; fulranumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	PROC 273 319	evaluar la eficacia, seguridad y tolerabilidad
T8	PROC 337 348	monoterapia
#4	AnnotatorNotes T8	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T9	DISO 364 381	signos y síntomas
#5	AnnotatorNotes T9	C0037088; Signs and Symptoms; Sign or Symptom
T10	DISO 385 413	artrosis de cadera o rodilla
T11	ANAT 406 413	rodilla
#6	AnnotatorNotes T11	C0022742; Knee; Body Part, Organ, or Organ Component | C1283838; Entire knee region; Body Location or Region | C1963703; Knee region structure; Body Location or Region
T12	DISO 437 465	Artrosis de cadera o rodilla
T13	ANAT 458 465	rodilla
#7	AnnotatorNotes T13	C0022742; Knee; Body Part, Organ, or Organ Component | C1283838; Entire knee region; Body Location or Region | C1963703; Knee region structure; Body Location or Region
T14	PROC 494 513	Diagnóstico clínico
#8	AnnotatorNotes T14	C0332140; Diagnosis, clinical; Diagnostic Procedure
T15	DISO 517 545	artrosis de cadera o rodilla
T16	ANAT 538 545	rodilla
#9	AnnotatorNotes T16	C0022742; Knee; Body Part, Organ, or Organ Component | C1283838; Entire knee region; Body Location or Region | C1963703; Knee region structure; Body Location or Region
T17	DISO 696 704	artrosis
#10	AnnotatorNotes T17	C0029408; Degenerative polyarthritis; Disease or Syndrome
T18	ANAT 741 753	articulación
#11	AnnotatorNotes T18	C0022417; Joints; Body Space or Junction | C1269611; Entire joint; Body Space or Junction
T19	DISO 816 829	osteonecrosis
#12	AnnotatorNotes T19	C0029445; Bone necrosis; Pathologic Function
T20	DISO 837 866	artrosis de progresión rápida
#13	AnnotatorNotes T20	C3854438; Rapidly progressive osteoarthritis; Disease or Syndrome
T21	DISO 916 939	Trastornos neurológicos
#14	AnnotatorNotes T21	C0027765; nervous system disorder; Disease or Syndrome
T22	ANAT 136 142	cadera
#15	AnnotatorNotes T22	C0019552; Hip structure; Body Part, Organ, or Organ Component | C1281585; Entire hip region; Body Location or Region
T23	CHEM 83 93	Fulranumab
#16	AnnotatorNotes T23	C2981231; fulranumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T24	ANAT 397 403	cadera
#17	AnnotatorNotes T24	C0019552; Hip structure; Body Part, Organ, or Organ Component | C1281585; Entire hip region; Body Location or Region
T25	ANAT 449 455	cadera
#18	AnnotatorNotes T25	C0019552; Hip structure; Body Part, Organ, or Organ Component | C1281585; Entire hip region; Body Location or Region
T26	ANAT 529 535	cadera
#19	AnnotatorNotes T26	C0019552; Hip structure; Body Part, Organ, or Organ Component | C1281585; Entire hip region; Body Location or Region
T27	PROC 671 692	pruebas radiográficas
T28	DISO 831 833	ON
T29	Date 13 17	2014
T30	LIVB 112 119	sujetos
#20	AnnotatorNotes T30	C0681850; Study Subject; Group
T31	Duration 208 218	16 semanas
T32	LIVB 352 359	sujetos
#21	AnnotatorNotes T32	C0681850; Study Subject; Group
T33	Spec_cue 806 815	riesgo de
A1	Assertion T19 Speculated
A2	Assertion T28 Speculated
A3	Assertion T20 Speculated
#22	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#23	AnnotatorNotes T3	C0029410; Osteoarthritis of hip; Disease or Syndrome + C0409959; Osteoarthritis, Knee; Disease or Syndrome
#24	AnnotatorNotes T7	C0511730; Identify product efficacy and safety issues; Health Care Activity + C3274448; Tolerability Study; Research Activity
#25	AnnotatorNotes T10	C0029410; Osteoarthritis of hip; Disease or Syndrome + C0409959; Osteoarthritis, Knee; Disease or Syndrome
#26	AnnotatorNotes T12	C0029410; Osteoarthritis of hip; Disease or Syndrome + C0409959; Osteoarthritis, Knee; Disease or Syndrome
#27	AnnotatorNotes T15	C0029410; Osteoarthritis of hip; Disease or Syndrome + C0409959; Osteoarthritis, Knee; Disease or Syndrome
#28	AnnotatorNotes T27	C0043299; Diagnostic radiologic examination; Diagnostic Procedure
#29	AnnotatorNotes T28	C0029445; Bone necrosis; Pathologic Function
R1	Speculation Arg1:T33 Arg2:T19	
R2	Speculation Arg1:T33 Arg2:T28	
R3	Speculation Arg1:T33 Arg2:T20	
R4	Used_for Arg1:T23 Arg2:T2	
R5	Experiences Arg1:T30 Arg2:T23	
R6	Experiences Arg1:T30 Arg2:T3	
R7	Location_of Arg1:T22 Arg2:T3	
R8	Location_of Arg1:T4 Arg2:T3	
R9	Has_Duration_or_Interval Arg1:T5 Arg2:T31	
R10	Used_for Arg1:T6 Arg2:T8	
R11	Experiences Arg1:T32 Arg2:T6	
R12	Experiences Arg1:T32 Arg2:T9	
R13	Experiences Arg1:T32 Arg2:T10	
R14	Causes Arg1:T10 Arg2:T9	
R15	Location_of Arg1:T24 Arg2:T10	
R16	Location_of Arg1:T11 Arg2:T10	
R17	Location_of Arg1:T25 Arg2:T12	
R18	Location_of Arg1:T13 Arg2:T12	
R19	Location_of Arg1:T26 Arg2:T15	
R20	Location_of Arg1:T16 Arg2:T15	
T34	CONC 560 619	criterios definidos por el American College of Rheumatology
R21	Used_for Arg1:T34 Arg2:T14	
T35	PROC 706 729	clase Kellgren-Lawrence
#30	AnnotatorNotes T35	C3177117; Kellgren-Lawrence score; Finding
T36	Result_or_Value 730 733	≥ 2
R23	Has_Result_or_Value Arg1:T35 Arg2:T36	
R25	Location_of Arg1:T18 Arg2:T35	
R26	Location_of Arg1:T18 Arg2:T17	
R27	Location_of Arg1:T18 Arg2:T27	
R29	Location_of Arg1:T26 Arg2:T27	
R30	Location_of Arg1:T16 Arg2:T27	
T37	Quantifier_or_Qualifier 940 950	inestables
R31	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T37	
T38	Quantifier_or_Qualifier 953 964	progresivos
#31	AnnotatorNotes T38	C0205329; Progressive; Functional Concept
R32	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T38	
A4	Experiencer T30 Patient
A5	Experiencer T32 Patient
